Suppr超能文献

印度注射技术研究:注射并发症、教育与医疗保健专业人员

Indian Injection Technique Study: Injecting Complications, Education, and the Health Care Professional.

作者信息

Kalra Sanjay, Mithal Ambrish, Sahay Rakesh, John Mathew, Unnikrishnan A G, Saboo Banshi, Ghosh Sujoy, Sanyal Debmalya, Hirsch Laurence J, Gupta Vandita, Strauss Kenneth W

机构信息

Bharti Hospital, Kunjpura Road, Karnal, India.

Medanta the Medicity, CH Baktawar Singh Road, Sector 38, Gurugram, Haryana, India.

出版信息

Diabetes Ther. 2017 Jun;8(3):659-672. doi: 10.1007/s13300-017-0244-9. Epub 2017 Mar 13.

Abstract

INTRODUCTION

Using the Indian and rest of world (ROW) injection technique questionnaire (ITQ) data, we address key insulin injection complications.

METHODS

In 2015 we conducted an ITQ survey throughout India involving 1011 patients. Indian values were compared with those from 41 other countries participating in the ITQ, known here as ROW.

RESULTS

More than a quarter of Indian insulin users described lesions consistent with lipohypertrophy (LH) at their injection sites and approximately 1 in 5 were found to have LH by the examining nurse (using visual inspection and palpation). Just over half of Indian injectors report having pain on injection. Of these, 4 out of 5 report having painful injections only several times a month or year (i.e., not with every injection). Doctors and diabetes educators in India (as opposed to nurses) have a larger role in teaching patients how to inject than they do in ROW. Despite this specialized approach, a very high percentage of patients report that they have not been trained (at least cannot remember being trained) in a wide range of essential injection topics. Only about 30% of Indian injectors get their sites checked at least annually, with nearly a third only having sites checked when they specifically complained and nearly 4 out of 10 never having had their sites checked.

CONCLUSION

Indian HCPs can clearly do a better job covering all the vital topics essential to proper injection habits.

摘要

引言

利用印度和世界其他地区(ROW)注射技术问卷(ITQ)数据,我们探讨了关键的胰岛素注射并发症。

方法

2015年,我们在印度各地对1011名患者进行了ITQ调查。将印度的数据与参与ITQ的其他41个国家(此处称为ROW)的数据进行比较。

结果

超过四分之一的印度胰岛素使用者描述其注射部位有与脂肪增生(LH)相符的病变,检查护士(通过视觉检查和触诊)发现约五分之一的患者有LH。略多于一半的印度注射者报告注射时有疼痛。其中,五分之四的人报告每月或每年只有几次注射疼痛(即并非每次注射都疼)。在印度,医生和糖尿病教育者(与护士不同)在教导患者如何注射方面所起的作用比在ROW更大。尽管采取了这种专门的方法,但仍有很高比例的患者报告称,他们没有接受过(至少不记得接受过)一系列基本注射主题的培训。只有约30%的印度注射者至少每年检查一次注射部位,近三分之一的人只有在专门提出抱怨时才检查部位,十分之四的人从未检查过注射部位。

结论

印度的医护人员显然可以在涵盖正确注射习惯所需的所有重要主题方面做得更好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验